AP NEWS

Conjunctivitis Therapeutics Markets, 2023 - Dominated by Akorn Incorporated, Allergan, Bausch Health, Novartis, and Santen Pharmaceutical - ResearchAndMarkets.com

February 13, 2019

DUBLIN--(BUSINESS WIRE)--Feb 13, 2019--The “Global Conjunctivitis Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The conjunctivitis therapeutics market will register a CAGR of over 8% by 2023.

The ease of availability of antibiotic eye drops and ointments for the treatment of bacterial conjunctivitis and antibiotics for viral conjunctivitis is leading to an increase in the use of these therapeutics.

The use of therapeutics is primarily to avoid the progression of the disease into severe indications, which could increase the economic burden of patients. Hence, the infectious nature of the disease is expected to increase the adoption rate of therapeutics, thus resulting in the growth of the market during the forecast period.

Growing allergy cases

Allergic conjunctivitis is caused by various types of allergies such as hay fever and asthma. Being allergic to substances such as dust mites and mold can also increase the risk of infection.

Globally, the prevalence of various types of allergies has been growing at a significant rate. The increasing prevalence of allergies such as dust mite allergy and pollen allergy increase the risk of allergic conjunctivitis.

Patent cliff

One of the major challenges faced by the global conjunctivitis therapeutics market is the patent expiration of various drugs in the market. Patent expiration leads to the increasing launch of generic drugs, thereby leading to value erosion of the global market.

The patent expiry of blockbuster drugs also impacts the sales of the vendors significantly, making it difficult for vendors to compete in the market. Thus, the patent expiry of blockbuster drugs and the subsequent entry of generics restrict market growth.

Competitive Landscape

The market appears to be concentrated and with the presence of very few vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Players

Akorn Incorporated Allergan Bausch Health Novartis AG Santen Pharmaceutical Co. Ltd.

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 04: MARKET SIZING

Market definition Market sizing 2018 Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 06: MARKET SEGMENTATION BY TYPE

Comparison by type Allergic conjunctivitis - Market size and forecast 2018-2023 Bacterial conjunctivitis - Market size and forecast 2018-2023 Viral conjunctivitis - Market size and forecast 2018-2023 Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

Overview Landscape disruption Competitive scenario

PART 12: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Akorn, Incorporated Allergan Bausch Health Novartis AG Santen Pharmaceutical Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/mqkpwh/conjunctivitis?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190213005401/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Optical ,Optical Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH OPTICAL PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/13/2019 07:59 AM/DISC: 02/13/2019 07:59 AM

http://www.businesswire.com/news/home/20190213005401/en

AP RADIO
Update hourly